Aortic diseases – diagnosis, classification and management principles

Česká verzia

Authors: P. Gavornik ^1,2,3; A. Dukát ^1,3; Ľ. Gašpar ^1,2,3; D. Medová ^1,2; M. Čaprnda ^1,3
Authors place of work: II. interná klinika LF UK a UN Bratislava ¹; Prvé angiologické pracovisko II. internej kliniky LF UK a UN Bratislava ²; Angiologická sekcia Slovenskej lekárskej komory ³
Published in the journal: Kardiol Rev Int Med 2014, 16(6): 493-500
Category: Cardiology Review

Summary

In addition to organovascular arterial ischemic diseases (cardiovascular, angiovascular, neurovascular, limbovascular, renovascular, genitovascular, bronchopulmonarovascular, mesenteriointestinokolonovascular, osteoarthromusculovascular, dermovascular, oculovascular, otovascular, stomatovascular, etc.), aortic diseases contribute to the wide spectrum of arterial diseases: aortic aneurysms (AA), acute aortic syndromes (AAS) including aortic dissection (AD), intramural hematoma (IMH), penetrating atherosclerotic ulcer (PAU) and traumatic aortic injury (TAI), pseudoaneurysm, aortic rupture, atherosclerosis, vasculitis as well as genetic diseases (e. g. Turner syndrome, Marfan syndrome, Ehlers‑ Danlos syndrome) and congenital abnormalities including coarctation of the aorta (CoA). Similarly to other arterial diseases, aortic diseases may be diagnosed after a long period of subclinical development or they may have an acute presentation. Acute aortic syndrome is often the first sign of the disease, which needs rapid diagnosis and decision making to overcome the extremely poor prognosis. Key clinical‑ etiology‑ anatomy‑ pathophysiology (CEAP) diagnostic aspects and principles of aortic disease management are discussed in this document (the Vessels project).

Keywords:
aorta – thoracic aorta – abdominal aorta – aortic diseases – classification – diagnosis – management

Zdroje

1. Erbel R, Aboyans V, Boileau C et al. 2014 ESC Guidelines on the diagnosis and treatment of aortic diseases. Document covering acute and chronic aortic diseases of the thoracic and abdominal aorta of the adult. The Task Force for the Diagnosis and Treatment of Aortic Diseases of the European Society of Cardiology (ESC). Eur Heart J 2014; 35: 2873– 2926. doi:10.1093/ eurheartj/ ehu281.

2. Gašpar Ľ. 40. výročie vzniku prvého klinického angiologického pracoviska na Slovensku a 20. výročie založenia Angiologickej sekcie Slovenskej lekárskej komory. Medikom 2014; 4: 66– 67.

3. Gavorník P. Všeobecná angiológia. Angiologická propedeutika. Cievne choroby. 2. vyd. Bratislava: Vydavateľstvo Univerzity Komenského 2001: 268.

4. Gavorník P. Angiológia 2 pre všeobecných praktických lekárov‑ Arteriológia. 1. vyd. Bratislava: Dr. Josef Raabe 2014: 174.

5. Gavorník P. Cielené vysvetľovanie cievnych chorôb a cievnych porúch. Vnitř Lék 2009; 55: 996– 997.

6. Olin JW, Gornik HL, Bacharach JM et al. American Heart Association Council on Peripheral Vascular Disease, Council on Clinical Cardiology, Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation, Council on Cardiovascular Disease in the Young, Council on Cardiovascular Radiology and Intervention, Council on Epidemiology and Prevention, Council on Functional Genomics and Translational Biology, Council for High Blood Pressure Research, Council on the Kidney in Cardiovascular Disease, and Stroke Council. Fibromuscular dysplasia: state of the science and critical unanswered questions: a scientific statement from the American Heart Association. Circulation 2014; 129: 1048– 1078. doi: 10.1161/ 01.cir.0000442577.96802.8c.

7. Anderson JL, Halperin JL, Albert NM et al. Management of patients with peripheral artery disease (compilation of 2005 and 2011 ACCF/ AHA guideline recommendations): a report of the American College of Cardiology Foundation/ American Heart Association Task Force on Practice Guidelines. Developed in Collaboration With the Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society for Vascular Medicine, and Society for Vascular Surgery. Circulation 2013; 127: 1425– 1443. doi: 10.1161/ CIR.0b013e31828b82aa.

8. Arcidiacono MV, Traveset A, Rubinat E et al. Microangiopathy of large artery wall: neglected complication of diabetes mellitus. Atherosclerosis 2013; 228: 142– 147. doi: 10.1016/ j.atherosclerosis.2013.02.011.

9. Mancia G, Fagard R, Narkiewicz K et al. 2013 ESH/ ESC Guidelines for the management of arterial hypertension. The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2013; 34: 2281– 2329. doi: 10.1093/ eurheartj/ eht151.

10. Tendera M, Aboyans V, Bartelink ML et al. ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries. The Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC). Eur Heart J 2011; 32: 2851– 2906. doi: 10.1093/ eurheartj/ ehr211.

11. Antignani PL, Benedetti‑ Valentini F, Aluigi L et al. Diagnosis of vascular diseases. Ultrasound investigations – Guidelines. Int Angiol 2012; 31 (Suppl 1): 1– 79.

12. Bays H. Adiposopathy, “sick fat,” Ockham’s razor, and resolution of the obesity paradox. Curr Atheroscler Rep 2014; 16: 409. doi: 10.1007/ s11883‑ 014‑ 0409‑ 1.

13. López‑ Mejías R, Genre F, González‑ Juanatey C et al. Autoantibodies and biomarkers of endothelial cell activation in atherosclerosis. Vasa 2014; 43: 83– 85. doi: 10.1024/ 0301‑ 1526/ a000333.

14. Papadakis MA, McPhee SJ, Rabow MW (eds). Current Medical Diagnosis and Treatment 2014 (Lange Current Series). 53rd ed. San Francisco: McGraw‑ Hill Medical 2013: 1840.

15. Rydén L, Grant PJ, Anker SD et al. ESC Guidelines on diabetes, pre‑diabetes, and cardiovascular diseases developed in collaboration with the EASD. The Task Force on diabetes, pre‑diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD). Eur Heart J 2013; 34: 3035– 3087. Corrigendum: Eur Heart J 2014; 35: 1824. doi: 10.1093/ eurheartj/ eht108.

16. Gavorník P. Končatinovocievne ischemické choroby. B 2.1/ 1– 92. In: Gavorník P, Hrubiško M, Rozborilová E (eds). Diferenciálna diagnostika kardio‑ vaskulárnych, respiračných a hematologických ochorení I. 1st ed. Bratislava: Dr. Josef Raabe 2010: 300.

17. Guyatt GH, Norris SL, Schulman S et al. Antithrombotic Therapy and Prevention of Thrombosis. 9th ed. American College of Chest Physicians (ACCP) evidence‑based clinical practice guidelines. Chest 2012; 141 (Suppl 1): 53S– 70S. doi: 10.1378/ chest.11‑ 2288.

18. Ip JH, Fuster V, Badimon L et al. Syndromes of accelerated atherosclerosis: Role of vascular injury and smooth muscle cell proliferation. J Am Coll Cardiol 1990; 15: 1667– 1687.

19. Bergqvist D, Björck M, Lees T et al. Validation of the VASCUNET registry – pilot study. Vasa 2014; 43: 141– 144. doi: 10.1024/ 0301‑ 1526/ a000340.

20. George JN, Nester CM. Syndromes of Thrombotic Microangiopathy. N Engl J Med 2014; 371: 654– 666. doi: 10.1056/ NEJMra1312353.

21. James PA, Oparil S, Carter BL et al. 2014 Evidence‑ Based Guideline for the Management of High Blood Pressure in Adults: Report From the Panel Members Appointed to the Eighth Joint National Committee (JNC 8) Novelty and Significance. JAMA 2014; 311: 507– 520. doi: 10.1001/ jama.2013.284427.

22. Eckel RH, Jakikic JM, Ard JD et al. 2013 AHA/ ACC Guideline on Lifestyle Management to Reduce Cardiovascular Risk: A Report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines. Circulation 2014; 129 (Suppl 2):S76– S99. doi: 10.1161/ 01.cir.0000437740.48606.d1.

23. Nuñez Fernández MJ, Bermúdez CF, Muñoz DD et al. IgG4‑related disease and isolated thoracic aortic aneurysm. Vasa 2014; 43: 385– 389. doi: 10.1024/ 0301‑ 1526/ a000375.

24. Stanley JC, Veith F, Wakefield TW (eds). Current Therapy in Vascular and Endovascular Surgery. 5th ed. Philadelphia. Elsevier Inc 2014: 1040. ISBN: 978- 1-4557- 0984- 7.

25. Creager MA, Beckman JA, Loscalzo J (eds). Vascular Medicine. A companion to Braunwald’s Heart Disease. Second edition. Philadelphia: Elsevier Saunders 2013: 832.

26. Grundy SM, Arai H, Barter P et al. Expert Dyslipidemia Panel of the International Atherosclerosis Society. An International Atherosclerosis Society Position Paper: global recommendations for the management of dyslipidemia‑ Full report. J Clin Lipidol 2014; 8: 29– 60. doi: 10.1016/ j.jacl.2013.12.005.

27. Schwarcz AI, Quijano A, Olin JW et al. Internal medicine interns have a poor knowledge of peripheral arterial disease. Angiology 2012; 63: 597– 602. doi: 10.1177/ 0003319711435148.

28. Gavorník P, Dukát A, Gašpar Ľ. Súčasnosť a budúcnosť farmako‑ artériotromboprofylaxie v klinickej praxi. Dokument (Odporúčania) Sekcie angiológov Slovenskej lekárskej komory (SA SLK, 2013). Vnitř Lék 2013; 59: 1081– 1087.

29. Gavorník P, Dukát A, Gašpar Ľ. Manažment stabilnej anginy pectoris a iných foriem chronickej kardiovaskulárnej artériovej choroby. Vnitř Lék 2012; 58: 29– 36.

30. Demer LL, Tintut Y. Inflammatory, metabolic, and genetic mechanisms of vascular calcification. Arterioscler Thromb Vasc Biol 2014; 34: 715– 723. doi: 10.1161/ ATVBAHA.113.302070.

31. Brown NK, Zhou Z, Zhang J et al. Perivascular adipose tissue in vascular function and disease. A review of current research and animal models. Arterioscler Thromb Vasc Biol 2014; 34: 1621– 1630. doi: 10.1161/ ATVBAHA.114.303029.

32. Kramer MH, Bauer W, Dicker D et al. Working Group on Professional Issues, European Federation of Internal medicine (EFIM). The changing face of internal medicine: patient centred care. Eur J Intern Med 2014; 25: 125– 127. doi: 10.1016/ j.ejim.2013.11.013.

33. Inventory, classification and encyclopeadia of rare diseases, with genes involved. [online] Available from: http:/ / www.orpha.net/ consor/ cgi‑ bin/ index.php?lng=EN.